Urologic Oncology Fellowship Faculty

The genitourinary oncologists at Moffitt are nationally recognized leaders in the treatment of urologic malignancies.  

Program Director
Michael Poch, MD 
Michael.Poch@Moffitt.org
Dr. Poch's clinical interests include bladder, kidney and prostate cancer with an emphasis on minimally invasive surgery and robotics. 

Associate Program Director

Logan Zemp, MD 
Logan.Zemp@Moffitt.org
Dr. Zemp’s clinical focus is the management of urologic malignancies including kidney, bladder, prostate and testis cancer. 

Julio Pow-Sang, MD
Department Chair
Dr. Pow-Sang is a principal investigator for numerous genitourinary cancer clinical trials and is a member of the prostate cancer guidelines panel for the National Comprehensive Cancer Network.

Scott Gilbert, MD
Dr. Gilbert has particular interest and expertise in bladder and testis cancer, and offers open, laparoscopic and robot-assisted procedures, nerve and organ-sparing approaches and complex salvage and reconstructive surgeries.

Roger Li, MD
Dr. Li's clinical practice focuses on the surgical treatment of bladder, prostate, kidney and penile cancers.

Adam Luchey, MD 
Dr. Luchey’s clinical interests include kidney, bladder, and prostate GU malignancies. His research interests include surgical education and health outcomes.

Brandon Manley, MD
Dr. Manley’s clinical practice centers on malignant tumors of the prostate, kidneys, bladder and testis. 

Marilin Nicholson, MD
Dr. Nicholson's clinical interests encompass various aspects of adult general urology, including robotic surgery, stone disease, male and female urinary dysfunction including benign prostatic hyperplasia (BPH), stress/urge incontinence, neurogenic bladder and male sexual medicine including erectile dysfunction (ED), low testosterone, Peyronie’s disease. 

Rodrigo Rodrigues Pessoa, MD, PhD 
Dr. Pessoa is a genitourinary oncologist who specializes in the surgical treatment of prostate, bladder, kidney and testicular cancers. He offers a variety of treatment options including open and minimally invasive procedures such as robotic-assisted and focal therapy interventions.

Wade Sexton, MD
Assistant Chief Medical Officer; Director of Robotic Surgery, Moffitt McKinley Hospital
Dr. Sexton’s academic and clinical practice is focused on bladder, kidney and advanced testicular malignancies.  

Philippe Spiess, MD
Assistant Chief of Surgical Services
Dr. Spiess’ research interests include novel therapies for advanced renal, bladder and penile cancer.

Alice Yu, MD
Dr. Yu’s clinical practice focuses on the surgical treatment of urologic cancers including prostate, bladder, kidney, penile and testicular cancer, using minimally invasive (laparoscopic and robotic) and open techniques.